Source: Frontiers in immunology. Unidade: FM
Subjects: AUTOANTICORPOS, MICRORNAS, DIABETES MELLITUS, AUTOIMUNIDADE
ABNT
SANTOS, Aritania S et al. Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes. Frontiers in immunology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.01637. Acesso em: 17 out. 2024.APA
Santos, A. S., Cunha-Neto, E., Fukui, R. T., Ferreira, L. R. P., & Silva, M. E. R. (2019). Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes. Frontiers in immunology, 10. doi:10.3389/fimmu.2019.01637NLM
Santos AS, Cunha-Neto E, Fukui RT, Ferreira LRP, Silva MER. Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes [Internet]. Frontiers in immunology. 2019 ; 10[citado 2024 out. 17 ] Available from: https://doi.org/10.3389/fimmu.2019.01637Vancouver
Santos AS, Cunha-Neto E, Fukui RT, Ferreira LRP, Silva MER. Increased expression of circulating microRNA 101-3p in type 1 diabetes patients: new insights into miRNA-regulated pathophysiological pathways for type 1 diabetes [Internet]. Frontiers in immunology. 2019 ; 10[citado 2024 out. 17 ] Available from: https://doi.org/10.3389/fimmu.2019.01637